Related Experiment Video

Updated: Jun 22, 2026

Visualizing Angiogenesis by Multiphoton Microscopy In Vivo in Genetically Modified 3D-PLGA/nHAp Scaffold for Calvarial Critical Bone Defect Repair
09:34

Visualizing Angiogenesis by Multiphoton Microscopy In Vivo in Genetically Modified 3D-PLGA/nHAp Scaffold for Calvarial Critical Bone Defect Repair

Published on: September 7, 2017

Making up or breaking up: the tortuous role of platelet-derived growth factor in vascular ageing

Xiao-Ping Yang1, Zhao-Hui Pei, Jun Ren

  • 1Center for Cardiovascular Research and Alternative Medicine, University of Wyoming College of Health Sciences, Laramie, Wyoming 82071, USA.

Clinical and Experimental Pharmacology & Physiology
|May 29, 2009
PubMed

Insights

Vascular smooth muscle cell (VSMC) proliferation, driven by platelet-derived growth factor (PDGF), is key to vascular ageing and cardiovascular disease. This review details PDGF's role in VSMC proliferation and ageing mechanisms.

Area of Science:

  • Cardiovascular Science
  • Vascular Biology
  • Cellular Aging

Background:

  • Aging is a major risk factor for cardiovascular diseases, leading to increased morbidity and mortality.
  • Age-associated vascular remodeling includes changes in vessel wall structure and increased stiffness.
  • Vascular smooth muscle cell (VSMC) migration and proliferation are critical in vascular aging.

Purpose of the Study:

  • To review recent findings on the role of platelet-derived growth factor (PDGF) in VSMC proliferation.
  • To elucidate the involvement of PDGF in the process of vascular aging.
  • To emphasize the cell signaling pathways implicated in PDGF-mediated VSMC proliferation and vascular aging.

Main Methods:

  • Literature review of experimental and clinical studies.
  • Analysis of cell signaling mechanisms.
  • Focus on the role of PDGF in VSMC proliferation.

Main Results:

  • PDGF plays a crucial role in VSMC proliferation, an early sign of arteriosclerosis and vascular aging.
  • Specific cell signaling pathways mediating PDGF's effects on VSMC are highlighted.
  • Evidence links PDGF-driven VSMC proliferation to age-related vascular changes.

Conclusions:

  • PDGF is a significant factor in VSMC proliferation and vascular aging.
  • Understanding PDGF signaling pathways is vital for addressing age-related cardiovascular pathology.
  • Further research into PDGF's role can inform therapeutic strategies for vascular aging.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.